Great Lakes Pharma Raises $3.1 Million
Great Lakes Pharmaceuticals Inc., a Cleveland-based developer of an antimicrobial catheter lock solution, has raised $3.1 million in Series B funding. Charter Life Sciences led the round, and was joined by Early Stage Partners and return backers Everett Partners, Ohio TechAngel Fund and North Coast Angel Fund.
27 July 2010•4 mins read
